Reports & Indexes★ Must Know

NITI Aayog releases 8th Trade Watch Quarterly; flags China dependence for pharma APIs

Tuesday, 23 June 2026 5 min readSource: PIBArticle 1 of 8

NITI Aayog released the 8th edition of its Trade Watch Quarterly (for Q4 FY26, January-March 2026) on June 23, 2026, with a thematic focus on the pharmaceutical sector. The report said India's overall trade grew 5.4% in Q4FY26, powered by services exports which rose 9% year-on-year to $111.1 billion (a services trade surplus of $60.4 billion), even as merchandise exports fell 2.8% to $112 billion. It flagged that India remains about 65% dependent on China for pharmaceutical ingredients (APIs/KSMs) and urged the country to move beyond low-cost generics into biologics, vaccines and advanced therapies. NITI Aayog Vice-Chairman Ashok Lahiri released the report, which also proposed a 'model pharma chapter' for future free-trade agreements. NITI Aayog separately released its 'DPI@2047' roadmap on digital public infrastructure.

Key Facts & Details

8 points

1
NITI Aayog released the 8th Trade Watch Quarterly (Q4 FY26) on June 23, 2026, themed on pharmaceuticals.
2
India's overall trade grew 5.4% in Q4FY26; services exports rose 9% YoY to $111.1 billion (surplus $60.4 billion).
3
Merchandise exports fell 2.8% to $112 billion in the quarter.
4
The report flagged India's ~65% dependence on China for pharma ingredients (APIs) and urged a move beyond generics.
5
It proposed a 'model pharma chapter' for future FTAs; released by NITI Aayog VC Ashok Lahiri.

Deep Dive

+
Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) are the building blocks of medicines; India imports a large share from China.
+
NITI Aayog is the government's apex public-policy think tank, chaired by the Prime Minister, with a Vice-Chairman as its operational head.
+
India is often called the 'pharmacy of the world' for its large generic-drug and vaccine exports.

Exam Focus

Examiners may test the publisher (NITI Aayog), the report (Trade Watch Quarterly, 8th edition), the theme (pharma), the China-API dependence (~65%) and the Q4FY26 trade growth (5.4%).

Exam Relevance & Angle

NITI Aayog reports and India's trade data are core economy GA; the report name, the pharma theme, the China-dependence figure and the services-vs-goods split are exact exam hooks.

Target Exams

SBI POIBPS PORBI Grade BNABARD Grade ASSC CGLUPSC CSEState PCS

Background & Context

NITI Aayog (National Institution for Transforming India), established in 2015 to replace the Planning Commission, is the Union government's premier policy think tank. It is chaired by the Prime Minister, with a Vice-Chairman (currently Ashok Lahiri in this context) heading day-to-day work. Its Trade Watch Quarterly is a periodic publication analysing India's external trade — merchandise and services — with a thematic deep-dive each edition. Active Pharmaceutical Ingredients (APIs) are the chemically active components of medicines; India's strong formulations industry relies heavily on imported APIs, a large share from China, which the government has sought to reduce through schemes such as the PLI for bulk drugs.